Sentinel lymph node detection by blue dye versus indocyanine green fluorescence imaging in colon cancer

Anticancer Research

Volumn 36, Issue 9, 2016, Pages 4853-4858

  Liberale, Gabriel ^a   Vankerckhove, Sophie ^b   Gomez Galdon, Maria ^c   Larsimont, Denis ^c   Ahmed, Bissan ^b   Bouazza, Fikri ^a   Moreau, Michel ^a   El Nakadi, Issam ^a   Donckier, Vincent ^a   Bourgeois, Pierre ^b  

^a JULES BORDET INSTITUTE   (Belgium)

^b Nuclear Medicine and Clinic Unit of Lymphology   (Belgium)

^c Department of Pathology ^*  (Italy)

Author keywords

Colorectal neoplasms; Fluorescence imaging; Indocyanine green; Lymph node; TNM staging

Indexed keywords

ADULT; AGED; ARTICLE; BLUE DYE FLUORESCENCE IMAGING; BODY MASS; CANCER STAGING; CLINICAL ARTICLE; COLON CANCER; COLON RESECTION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ELECTIVE SURGERY; EX VIVO STUDY; FALSE NEGATIVE RESULT; FEMALE; FLUORESCENCE IMAGING; HUMAN; INDOCYANINE GREEN FLUORESCENCE IMAGING; INTERMETHOD COMPARISON; MALE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE METASTASIS; VERY ELDERLY; COLON TUMOR; DIAGNOSTIC IMAGING; LYMPH NODE METASTASIS; MIDDLE AGED; PATHOLOGY; SENTINEL LYMPH NODE;

INDOCYANINE GREEN;

ADULT; AGED; AGED, 80 AND OVER; COLONIC NEOPLASMS; FEMALE; HUMANS; INDOCYANINE GREEN; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; OPTICAL IMAGING; SENTINEL LYMPH NODE;

EID: 84991573477     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: 10.21873/anticanres.11048     Document Type: Article

References (25)

1. André T, de Gramont A, Vernerey D, Chibaudel B, Bonnetain F, Tijeras-Raballand A, Scriva A, Hickish T, Tabernero J, Van Laethem JL, Banzi M, Maartense E, Shmueli E, Carlsson GU, Scheithauer W, Papamichael D, Möehler M, Landolfi S, Demetter P, Colote S, Tournigand C, Louvet C, Duval A, Fléjou JF, and de Gramont A: Adjuvant fluorouracil, leucovorin, and oxaliplatin in stage II to III colon cancer: updated 10-year survival and outcomes according to BRAF mutation and mismatch repair status of the MOSAIC study. J Clin Oncol 33: 4176-4187, 2015.
2. Edge SB, Byrd DR and Compton CC: AJCC Cancer Staging Manual, Seventh Edition. Springer, New York, 2010.
3. Figueredo A, Coombes ME and Mukherjee S: Adjuvant therapy for completely resected stage II colon cancer. Cochrane Database Syst Rev 3: CD005390, 2008.
4. Dummer R, Hauschild A, Guggenheim M, Jost L, Pentheroudakis G and ESMO Guidelines Working Group: Melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 21: v194-v197, 2010.
5. Lyman GH, Temin S, Edge SB, Newman LA, Turner RR, Weaver DL, Benson AB III, Bosserman LD, Burstein HJ, Cody H III, Hayman J, Perkins CL, Podoloff DA and Giuliano AE: American Society of Clinical Oncology Clinical Practice. Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 32: 1365-1383, 2014.
6. Bilchik A, Saha S, Wiese D, Stonecypher JA, Wood TF, Sostrin S, Turner RR, Wang HJ, Morton DL and Hoon DS: Molecular staging of early colon cancer on the basis of sentinel node analysis: a multicenter phase II trial. J Clin Oncol 19: 3238-3244, 2001.
7. van der Pas MHGM, Meijer S, Hoekstra OS, Riphagen II, de Vet HC, Knol DL, van Grieken NC and Meijerink WJ: Sentinellymph-node procedure in colon and rectal cancer: a systematic review and meta-analysis. Lancet Oncol 12: 540-550, 2011.
8. Nicastri DG, Doucette JT, Godfrey TE and Hugues SJ: Is occult lymph node disease in colorectal cancer patients clinically significant? A review of the relevant literature. J Mol Diagn 9: 563-571, 2007.
9. Sloothaak DAM, Sahami S, van der Zaag-Loonen HJ van der Zaag ES, Tanis PJ, Bemelman WA and Buskens CJ: The prognostic value of micrometastases and isolated tumours cells in histologically negative lymph nodes of patients with colorectal cancer: a systematic review and meta-analysis. Eur J Surg Oncol 40: 263-269, 2014.
10. Hirche C, Murawa D, Mohr Z, Kneif S and Hünerbein M: ICG fluorescence-guided sentinel node biopsy for axillary nodal staging in breast cancer. Breast Cancer Res Treat 121: 373-378, 2010.
11. Gilmore DM, Khullar OV, Gioux S, Stockdale A, Frangioni JV, Colson YL and Russell SE: Effective low-dose escalation indocyanine green for near-infrared fluorescent sentinel lymph node mapping in melanoma. Ann Surg Oncol 20: 2357-2363, 2013.
12. Rossi EC, Ivanova A and Boggess JF: Robotically assisted fluorescence-guided lymph node mapping with ICG for gynecologic malignancies: a feasibility study. Gynecol Oncol 124: 78-82, 2012.
13. Kusano M, Tajima Y, Yamazaki K, Kato M, Watanabe M and Miwa M: Sentinel Node Mapping Guided by Indocyanine Green Fluorescence Imaging: A New Method for Sentinel Node Navigation Surgery in Gastrointestinal Cancer. Dig Surg 25: 103-108, 2008.
14. Hirche C, Mohr Z, Kneif S, Doniga S, Murawa D, Strik M and Hünerbein M: Ultrastaging of colon cancer by sentinel node biopsy using fluorescence navigation with indocyanine green. Int J Colorectal Dis 7: 319-324, 2012.
15. Noura S, Ohue M, Seki Y, Tanaka K, Motoori M, Kishi K, Miyashiro I, Ohigashi H, Yano M, Ishikawa O and Miyamoto Y: Feasibility of a lateral region sentinel node biopsy of lower rectal cancer guided by indocyanine green using a near-infrared camera system. Ann Surg Oncol 17: 144-151, 2010.
16. Nagata K, Endo S, Hidaka E, Tanaka J, Kudo SE and Shiokawa A: Laparoscopic sentinel node mapping for colorectal cancer using infrared ray laparoscopy. Anticancer Res 26: 2307-2312, 2006.
17. Kitagawa Y, Fujii H, Kumai K, Kubota T, Otani Y, Saikawa Y, Yoshida M, Kubo A and Kitajima M: Recent advances in sentinel node navigation for gastric cancer: a paradigm shift of surgical management. J Surg Oncol 90: 147-151, 2005.
18. Bembenek AE, Rosenberg R, Wagler E, Gretschel S, Sendler A, Siewert JR, Nährig J, Witzigmann H, Hauss J, Knorr C, Dimmler A, Gröne J, Buhr HJ, Haier J, Herbst H, Tepel J, Siphos B, Kleespies A, Koenigsrainer A, Stoecklein NH, Horstmann O, Grützmann R, Imdahl A, Svoboda D, Wittekind C, Schneider W, Wernecke KD and Schlag PM: Sentinel lymph node biopsy in colon cancer: a prospective multicenter trial. Ann Surg 245: 858-863, 2007.
19. Liberale G, Lasser P, Sabourin JC, Malka D, Duvillard P, Elias D, Boige V, Goéré D, Ducreux M and Pocard M: Sentinel lymph nodes of colorectal carcinoma: reappraisal of 123 cases. Gastroenterol Clin Biol 31: 281-285, 2007.
20. Oh SY, Kim DY, Kim YB and Suh KW. Clinical application of sentinel lymph node mapping in colon cancer: in vivo vs. ex vivo techniques. Ann Surg Treat Res 87: 118-122, 2014.
21. Wood TF, Saha S, Morton DL, Tsioulias GJ, Rangel D, Hutchinson W Jr, Foshag LJ and Bilchik AJ: Validation of lymphatic mapping in colorectal cancer: in vivo, ex vivo, and laparoscopic techniques. Ann Surg Oncol 8: 150-157, 2001.
22. Greenson JK, Isenhart CE, Rice R, Mojzisik C, Houchens D and Martin EW Jr: Identification of occult micrometastases in pericolic lymph nodes of Duke's B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Correlation with long term survival. Cancer 73: 563-569, 1994.
23. Bukholm IR, Bondi J, Wiik P, Nesland JM, Andersen SN, Bakka A and Bukholm G: Presence of isolated tumor cells in mesenteric lymph nodes predicts poor prognosis in patients with stage II colon cancer. Eur J Surg Oncol 29: 862-866, 2003.
24. Liefers GJ, Cleton-Jansen AM, van de Velde CJ, Hermans J, van Krieken JH, Cornelisse CJ and Tollenaar RA: Micrometastases and survival in stage II colorectal cancer. N Engl J Med 339: 223-228, 1998.
25. Lips DJ, Koebrugge B, Liefers GJ, van de Linden JC, Smit VT, Pruijt HF, Putter H, van de Velde CJ and Bosscha K: The influence of micrometastases on prognosis and survival in stage I-II colon cancer patients: the Enroute? Study. BMC Surgery 11: 11, 2011.